Novo-Nordisk A/S(us:NVO)

    87.37

    -1.51%

    Updated on 2024-12-25

    Open:88.90
    Close:87.37
    High:88.98
    Low:87.07
    Pre Close:88.71
    Volume:4.77M
    Amount:417.73M
    Turnover:0.11%
    Shares:4.44B
    MarketCap:388.07B

    About Novo-Nordisk A/S Company

    Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsv?rd, Denmark.

    Company Name: Novo-Nordisk A/S
    Company Address: Novo Allé 1
    Employees: 64319
    Fiscar Year: 12-31
    IPO Date: 1981-07-09
    CIK: 353278

    View all SEC Filings

    About

    Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsv?rd, Denmark.
    Address:Novo Allé 1

    Market Movers